Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015
Cash flow from operating activities:
Net Income (loss)	$ (35,781)	$ 3,892
Adjustments:
Depreciation and amortization expense	1,267	1,532
Equity-based compensation expense	1,322	966
Deferred income taxes	(541)	403
Deferred compensation	85	(95)
Goodwill impairment	37,329
Write-off of capitalized software		1,180
Changes in assets and liabilities:
Increase in accounts receivable	(1,730)	(9,084)
Increase in prepaid and other current assets	(956)	(816)
Increase in cash surrender value of life insurance	(1,064)	(637)
Decrease in accounts payable	(2,391)	(2,689)
Increase in accrued compensation	6,076	1,133
Increase (decrease) in advance billings on contracts	404	(542)
Decrease in other current liabilities	(285)	831
Increase (decrease) in other long-term liabilities	88	(7)
Net cash provided by (used) in operating activities	3,823	(3,933)
Cash flow from investing activities:
Additions to property and equipment	(1,529)	(872)
Additions to capitalized software	(370)	(641)
Life insurance proceeds	394
Deferred compensation plan investments, net	(119)	514
Net cash used in investing activities	(1,624)	(999)
Cash flow from financing activities:
Proceeds from (payments on) long-term debt, net	(725)	10,000
Proceeds from stock option plan exercises	229	2,066
Excess tax benefits from equity-based compensation	22	345
Proceeds from Employee Stock Purchase Plan	161	213
Change in cash overdraft, net	(226)	142
Dividends paid	(2,844)	(2,713)
Payments against loans on life insurance policies		(22,827)
Purchase of stock for treasury		(1,406)
Net cash used in financing activities	(3,383)	(14,180)
Effect of exchange rates on cash and cash equivalents	168	(805)
Net decrease in cash and cash equivalents	(1,016)	(19,917)
Cash and cash equivalents at beginning of year	10,801	40,862
Cash and cash equivalents at end of quarter	$ 9,785	$ 20,945